Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed5

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

NCT06621576Early Phase 1Completed
First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure
Heart FailureIschaemic Heart Disease
StudydirectorStart date: 2024-09-18
NCT04935086Completed
Risk Factors for Predictors of MACEs After RA-CABG
Coronary Artery Disease
PrincipalinvestigatorStart date: 2021-06-30
NCT04310995Phase 4Completed
Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts
Antispastic TherapyCoronary Artery Bypass GraftPilot Study+1 more
StudydirectorStart date: 2020-06-02
NCT03987373Completed
DACAB Trial: Follow-up Extension
Antiplatelet TherapyCoronary Artery Bypass Grafting
StudydirectorStart date: 2019-08-01

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mario FL Gaudino, MD

Weill Cornell Medicine NewYork Presbyterian Hospital

Similar
2 trials

Shared therapeutic areas:

Antiplatelet TherapyAntispastic TherapyCoronary Artery Bypass Graft+3 more

Worked with same sponsors:

Chugai Pharma ChinaRuijin Hospital
Collaborated on 2 trials
Similarity Score68%

Qiang Zhao, MD

Ruijin Hospital

Similar
5 trials

Shared therapeutic areas:

Coronary Artery BypassCoronary Artery DiseaseAntiplatelet Therapy+2 more

Worked with same sponsors:

Ruijin HospitalShanghai Bestudy Medical Technology Co., Ltd+1 more
Collaborated on 4 trials
Similarity Score66%

Qiang Zhao, MD.PhD

Ruijin Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Antispastic TherapyCoronary Artery Bypass GraftPilot Projects+1 more

Worked with same sponsors:

Chugai Pharma ChinaRuijin Hospital
Collaborated on 1 trial
Similarity Score44%

Jiaxi Zhu, MD

Ruijin Hospital

Related
1 trials

Shared therapeutic areas:

Coronary Artery Disease

Worked with same sponsors:

Ruijin Hospital
Collaborated on 1 trial
Similarity Score14%

Yang Yan

First Affiliated Hospital Xi'an Jiaotong University

Related
15 trials

Shared therapeutic areas:

Coronary Artery BypassHeart Failure
Similarity Score7%

Muhammad iqbal Tariq, PhD*

Riphah International University

Related
16 trials

Shared therapeutic areas:

Heart FailureCoronary Artery Disease
Similarity Score7%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score3%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score3%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score3%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Heart Failure
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06621576Early Phase 1StudyDirector

First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure

Heart FailureIschaemic Heart Disease
Completed
NCT05556590StudyDirector

Quantitative Flow Ratio on Radial Artery Graft Outcome After Coronary Artery Bypass Grafting

Coronary Artery Disease
Completed
NCT04935086PrincipalInvestigator

Risk Factors for Predictors of MACEs After RA-CABG

Coronary Artery Disease
Completed
NCT04310995Phase 4StudyDirector

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

Antispastic TherapyCoronary Artery Bypass GraftPilot Study+1 more
Completed
NCT03987373StudyDirector

DACAB Trial: Follow-up Extension

Antiplatelet TherapyCoronary Artery Bypass Grafting
Completed

All 5 trials loaded